Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 Biomarker group BEFREE The association between APOE-ε4 and four symptom dimensions was investigated in a longitudinal study of 116 individuals with schizophrenia initially assessed during their first admission for psychosis and evaluated five times over the following 20years. 30584027 2019
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 Biomarker group BEFREE Factorial design was used to assess the effects of psychosis and APOE ε4, as well as their interaction. 28847281 2018
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 Biomarker group BEFREE The following factors were identified to increase the risk of RCD in AD: Apolipoprotein E4 (ApoE4) (SMD [95% CI]: 0.52 [0.06,0.98]), early age at onset (SMD [95% CI]: -0.42 [-0.71, -0.13]), high level of education (RR = 2.05, 95% CI = 1.26 to 3.33), early appearance of extrapyramidal signs (RR = 2.18; 95% CI = 1.30 to 3.67), and neuropsychiatric conditions including hallucination (RR = 2.01, 95% CI = 1.40 to 2.87), strolling (RR = 1.99, 95% CI = 1.38 to 2.86), agitation (RR = 1.66, 95% CI = 1.23 to 2.24), and psychosis (RR = 1.42, 95% CI = 1.07 to 1.89). 30320579 2018
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 GeneticVariation group BEFREE The aim of the present study was to explore the relationship between Apolipoprotein E (APOE) genotype, Lewy body pathology, and psychosis in AD. 28219318 2017
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 Biomarker group BEFREE Genetic association between APOE*4 and neuropsychiatric symptoms in patients with probable Alzheimer's disease is dependent on the psychosis phenotype. 23270420 2012
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 GeneticVariation group BEFREE They first validated the model's ability to detect the previously established effects of APOE ε4 alleles on age at cognitive decline and of psychosis on the rate of cognitive decline in 802 subjects from the Cardiovascular Health Cognition Study who did not have dementia at study entry and developed incident dementia during follow-up. 22952074 2012
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 Biomarker group BEFREE Neither APOE ε4 nor poly-T repeat length was associated with psychosis. 21820212 2011
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 GeneticVariation group BEFREE To investigate the role of the apolipoprotein E (APOE) gene in schizophrenia, the authors analyzed 60 families with this mental disorder. 19996253 2009
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 Biomarker group BEFREE ApoE epsilon4 noncarriers showed better improvement in mean total BEHAVE-AD score and mean psychosis (delusions and hallucinations) subscale score than ApoE epsilon4 carriers. 16254428 2006
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 GeneticVariation group BEFREE APOE epsilon3/epsilon4 allele was carried by 20 patients (14 with psychosis), epsilon2/epsilon3 by 11 patients (10 with psychosis), epsilon3/epsilon3 by 55 patients (25 with psychosis) and epsilon2/epsilon4 by one patient who had psychosis. 16367893 2006
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 GeneticVariation group BEFREE Psychosis risk was not associated with ApoE4, COMT, or sex. 15852364 2005
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 GeneticVariation group BEFREE The objective of this study was to examine the effect of APOE4 and alpha1-antichymotrypsin/AA (ACT/AA) genotypes on time to psychosis onset in subjects with AD. 11936240 2002
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 GeneticVariation group BEFREE Schizophrenic patients with the apolipoprotein E (APOE = gene; apoE = protein) epsilon4 allele exhibited lower psychosis scores than patients without the epsilon4 allele in previous reports. 11096331 2000
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 GeneticVariation group BEFREE Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease. 10322238 1999